“Opportune Safety and Efficacy Information for Therapies Intended for COVID-19: Balancing Evidence and Expectations in an Emergency Context” (2020) Open Access Journal of Pharmaceutical Research, 4(2), pp. 1–3. doi:10.23880/oajpr-16000203.